EHAB News

Enhabit Home Health & Hospice Announces CEO Transition Plan

EHAB

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, intends to step down from these roles in July 2026, or upon the appointment of a successor. The company has initiated a leadership succession plan with Jacobsmeyer’s full support to ensure a smooth transition. The board has retained Russell Reynolds Associates, a leading executive search firm, to assist

Enhabit Reports Second Quarter 2025 Financial Results

EHAB

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2025. “Our second quarter results reflect strong execution of our strategic 2025 priorities, with sequential and year-over-year growth in revenue and Adjusted EBITDA,” said Barb Jacobsmeyer, president and CEO of Enhabit. “Home health continued to benefit from our payer contract initiatives as admissions grew 1.3% yea

August 6, 2025Earnings
Read more →

Enhabit Affirms FY2025 Adj EPS Guidance of $0.41-$0.51 vs $0.38 Est; Affirms FY2025 Sales Guidance of $1.05B-$1.08B vs $1.07B Est

EHAB

May 7, 2025
Read more →

Enhabit Q1 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $259.90M Miss $266.05M Estimate

EHAB

May 7, 2025
Read more →

Enhabit Sees FY2025 Adj EPS $0.41-$0.51 vs $0.29 Est; Sees Sales $1.050B-$1.080B vs $1.07B Est

EHAB

March 5, 2025
Read more →

Enhabit Q4 Adj $0.04 Misses $0.05 Estimate, Sales $258.20M Miss $259.11M Estimate

EHAB

March 5, 2025
Read more →

Leerink Partners Reiterates Market Perform on Enhabit, Lowers Price Target to $8

EHAB

November 19, 2024
Read more →

Enhabit Sees FY24 Adj. EPS $0.19-$0.29 Vs $0.27 Est.; Revenue $1.031B-$1.046B Vs 1.054B Est.

EHAB

November 6, 2024
Read more →

Enhabit Q3 2024 Adj. EPS $0.03 Misses $0.04 Estimate, Sales $253.600M Miss $261.645M Estimate

EHAB

November 6, 2024
Read more →